Octreotide Injection

DRUG4 trials

Sponsors

Centre Hospitalier Universitaire, Amiens, Fredrik Klevebro, Beijing Children's Hospital, Ikechukwu Bartholomew Ulasi

Conditions

Congenital Hyperinsulinaemic HypoglycaemiaEsophageal CancerGastric CancerHaemorrhagic ShockOctreotide Adverse ReactionSeroma Following ProcedureVariceal Hemorrhage

Phase 2

Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients with Esophageal or Gastric Cancer

CompletedNCT04871204

Fredrik KlevebroEsophageal Cancer, Gastric Cancer

Start: 2021-06-16End: 2024-02-21Updated: 2024-10-31

Phase 4

The Effect of Octreotide on Wound Drainage After Mastectomy

CompletedNCT05682209

Ikechukwu Bartholomew UlasiSeroma Following Procedure

Start: 2020-12-18End: 2021-12-02Updated: 2023-01-18

Unknown Phase

Macro and Microcirculatory Effects of the Combination of Norepinephrine and Octreotide for the Treatment of Cirrhotic Patients With Hemorrhagic Shock

WithdrawnNCT03891849

Centre Hospitalier Universitaire, AmiensHaemorrhagic Shock, Variceal Hemorrhage

Start: 2021-09-01End: 2023-05-31Updated: 2023-02-09

Efficacy and Safety Evaluation of Octreotide in the Treatment of Congenital Hyperinsulinemia

CompletedNCT05171751

Beijing Children's HospitalCongenital Hyperinsulinaemic Hypoglycaemia, Octreotide Adverse Reaction

Start: 2021-11-01End: 2021-12-18Updated: 2021-12-29